ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for discussion 같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.

OKYO Okyo Pharma Limited

91.00
0.00 (0.00%)
26 4월(4) 2024 - 마감
15분 지연
기업명 주식 심볼 시장 주식 타입
Okyo Pharma Limited OKYO 런던 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
0.00 0.00% 91.00 09:00:00
개장가 저가 고가 종가 전일 종가
91.00 91.00
시세 정보 더보기 »
산업 분야
MINING

최근 뉴스

일자 시간 출처 제목
09/04/202408:00UKREGOKYO Pharma to Reschedule Key Opinion Leader Event in Dry..
02/04/202420:00UKREGOKYO Pharma Announces Upcoming Presentation of OK-101 Phase..
22/03/202420:00UKREGOKYO Pharma Announces OK-101 Successfully Achieved..
21/03/202420:00UKREGOKYO Pharma to Host Key Opinion Leader Event to Discuss New..
20/03/202420:00UKREGOKYO Pharma to Release New and Comprehensive Data from Phase..
09/02/202421:36IHNWOKYO Pharma Receives FDA Approval of IND for OK-101 in..
09/02/202421:00UKREGOKYO Pharma Receives FDA Approval of IND for OK-101 in..
31/01/202421:00UKREGOKYO Pharma Announces Distinguished Ophthalmologists with..
08/01/202421:00GLOBEOKYO Pharma Announces OK-101 Successfully Achieved..
05/01/202423:30GLOBEOKYO Pharma to Present at the Biotech Showcase Conference in..
04/12/202321:00GLOBEOKYO Pharma Announces Last Patient Enrolled in OK-101 Phase..
31/10/202320:00GLOBEOKYO Pharma Announces $5.84 Million Cash Raise and Payables..
09/10/202320:00GLOBEOKYO Pharma Announces Filing of an Investigational New Drug..
05/10/202320:00GLOBEOKYO Pharma Announces Positive Safety Data Profile for the..
15/09/202320:00GLOBEOKYO Pharma Announces Closing of $4.0 Million Registered..
14/09/202322:15GLOBEOKYO Pharma Announces Pricing of $4.0 Million Registered..
14/09/202321:45GLOBEOKYO Pharma Limited Announces Withdrawal of Public Offering
14/09/202305:05GLOBEOKYO Pharma Announces Public Offering of Ordinary Shares
08/09/202320:00GLOBEOKYO Pharma Completes Enrollment in Phase 2 Clinical Trial..
30/08/202320:00GLOBEOKYO Pharma Achieves 90% Enrollment in 240-Patient Phase 2..
29/08/202320:00GLOBEOKYO Pharma Limited Regains Compliance with Nasdaq Listing..
15/08/202322:00GLOBEOKYO Pharma Limited Reports Annual Results for the Twelve..
31/07/202315:18GLOBEOKYO Pharma Limited Announces Withdrawal of Public Offering
29/07/202306:25GLOBEOKYO Pharma Announces Proposed Public Offering of Ordinary..
29/07/202306:05GLOBEOKYO Pharma Limited Receives Nasdaq Deficiency Notice
28/07/202320:01GLOBEOKYO Pharma Plans to Initiate Phase 2 Trial of OK-101 in..
28/07/202300:30GLOBEOKYO Pharma Announces Appointment of William A. Clementi as..
06/06/202322:30GLOBEOKYO Pharma Announces Randomized Segment Now Underway in..
22/05/202316:15UKREGOKYO Pharma Limited London Stock Exchange Delisting
22/05/202316:00UKREGLondon Stock Exchange Notice Cancellation - OKYO PHARMA..
19/05/202319:22ALNCNewsIN BRIEF: Okyo Pharma to move shares to New York with London..
19/05/202316:00RNSNONOKYO Pharma Limited ADS Program collapse
15/05/202315:00UKREGOKYO Pharma Limited Change of Record Time and Last Day of..
11/05/202322:27ALNCNewsIN BRIEF: Okyo Pharma delays delisting from London trading..
11/05/202320:00RNSNONOKYO Pharma Limited Webull Corporate Communications Service..
11/05/202315:00UKREGOKYO Pharma Limited Change of Delisting Date to 22 May 2023
03/05/202321:00UKREGOKYO Pharma Limited Result of Meeting
03/05/202315:00GLOBEOKYO Pharma Announces Presentations at the American Society..
03/05/202304:16ALNCNewsTRADING UPDATES: Knights Group buys St James Law and Baines..
02/05/202315:00GLOBEOKYO Pharma Announces First-Patient First-Visit for Phase 2..
02/05/202315:00UKREGOKYO Pharma Limited First-Patient First-Visit for Phase 2..

최근 히스토리

Delayed Upgrade Clock